Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEach Mounjaro KwikPen contains four weekly doses, and turning the dose knob produces an audible click for each unit of movement. A "half dose" in this context means dialling to the midpoint of a full weekly dose — but the number of clicks that represents changes at every strength, which is why this question comes up so often. Mounjaro is a prescription-only medicine; the dose you take, and whether any adjustment is appropriate, is a clinical decision made by your prescriber, not something to work out from a click count alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro KwikPen is a pre-filled, multi-dose device. Each pen holds enough medication for four weekly injections, and you dial your dose by rotating the knob until the correct number appears in the dose window. As you turn, the pen produces a series of clicks. These clicks are a tactile and audible confirmation that the dial is moving, they are not individual dose units in the way that, say, an insulin pen measures in 1-unit increments.
What that means practically: the number of clicks between zero and a full dose varies by pen strength. A 2.5 mg pen does not produce the same click count as a 10 mg pen dialled to its full position. So if someone asks "how many clicks is half a dose of Mounjaro," the answer depends entirely on which strength pen you are using. The mechanics of the Mounjaro KwikPen are described in detail in the Mounjaro SmPC on the eMC, which is the authoritative source for device instructions and should be read alongside the Patient Information Leaflet supplied with your pen.
A note that our prescribers hear most weeks: people often assume the click count is standardised across all Mounjaro strengths, and that a quick calculation will give them a safe midpoint. It does not work that way. The dose window number is the reliable guide; the click count is a secondary confirmation, not a primary measure. For practical guidance on using the device correctly, the step-by-step pen technique page walks through the process in detail.
The search for mounjaro half dose clicks almost always comes from one of two places: a tolerability concern (side effects, usually gastrointestinal, that feel more manageable at a lower amount) or a supply question (a partial pen, a delayed delivery, trying to make a pen last longer). Both are understandable, and neither should lead someone to self-adjust without clinical input.
Tirzepatide's licensed titration schedule, as described by the NHS medicines information for tirzepatide, starts at 2.5 mg and moves upward in prescribed steps (typically every four weeks) to find the right maintenance dose for each patient. Those steps exist because the dose-response relationship has been studied carefully; the increments are not arbitrary. Splitting doses outside that schedule is not part of the licensed pathway.
If tolerability is the issue, a prescriber can review whether slowing the titration, staying at a lower dose for longer, or other adjustments are right for you. That is a formal clinical decision, not a workaround. If supply is the issue, the same conversation applies. You can find context on how the dose schedule fits into long-term treatment on the Mounjaro maintenance dose page.
For anyone curious about the 5 mg pen specifically and what half of that dose would look like mechanically, the 5 mg half-dose clicks page covers that strength in full.
NICE's technology appraisal of tirzepatide (TA1026) and the licensed SmPC both frame dose decisions as prescriber-led. The SmPC specifies that if a patient cannot tolerate an increase, remaining at the current dose for longer before the next step is the recommended approach, not taking a fraction of the next dose.
This matters because informal dose splitting carries real risks. The pen is calibrated for full licensed increments. Dialling to an approximate midpoint gives you an approximate dose, not a precise one, and the pen's design does not guarantee accuracy at non-standard dial positions. For a medicine where consistency of dosing affects both tolerability and effectiveness, approximate is not good enough.
The wider clinical picture for Mounjaro (eligibility, what the trial evidence shows, and how it fits into a treatment plan) is covered on the Mounjaro treatment guide. If you are considering starting treatment or discussing a dose change, the free consultation at nume connects you with a GPhC-registered Independent Prescriber who reviews your case personally, the same day.
The most accurate source for the click count at any given strength is the Patient Information Leaflet included with your pen. Eli Lilly's device instructions describe the injection procedure step by step, and the leaflet is specific to the pen version you have received. The Mounjaro clicks and dose page also sets out the relationship between dial positions and doses across the licensed strengths, and the pen click guide addresses the half-dose question for each strength directly.
What none of those sources will tell you is that a self-calculated half dose is clinically appropriate for your situation. That assessment requires a prescriber to look at your full medical picture. If cost context is part of what you are weighing up, the Mounjaro cost and access page explains how UK private treatment is priced and what a legitimate prescription route includes. The short version: the right dose at the right time, reviewed by a real clinician, is what makes treatment effective. Mechanical shortcuts are not a substitute for that.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.